JaneCaryBurnsMD

Professor, Pediatrics, UCSD School of Medicine

Dr. Burns is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8001 Frost St
Entrance 9
San Diego, CA 92123
Phone+1 858-246-0155

Fax+1 858-309-6301

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 1983 - 1984
University of ColoradoFellowship, Infectious Disease, 1982 - 1983
University of ColoradoResidency, Pediatrics, 1978 - 1982
University of North Carolina at Chapel Hill School of MedicineClass of 1978

PubMed

1062 citations
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian ...
Jane C. Burns, Theodore Friedmann, Wolfgang Driever, Michelle Burrascano, Jiing-Kuan Yee
Proceedings of the National Academy of Sciences of the United States of America. 1993-09-01
474 citations
The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL
Zhonghan Li, Ti-Chun Chao, Kung-Yen Chang, Nianwei Lin, Veena S. Patil
Proceedings of the National Academy of Sciences of the United States of America. 2014-01-21
751 citations
Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawas...
Jane W. Newburger, Masato Takahashi, Michael A. Gerber, Michael H. Gewitz, Lloyd Y. Tani
Pediatrics. 2004-12-01

Journal Articles

Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2
Adriana Tremoulet, Jane C Burns, JAMA
Association of Initially Normal Coronary Arteries with Normal Findings on Follow-up Echocardiography in Patients with Kawasaki Disease
David R Fulton, Adriana H Tremoulet, Jane C Burns, Jane W Newburger, Kevin G Friedman, JAMA
Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature
John T Kanegaye, Adriana H Tremoulet, Jane C Burns, Mary P Glode, JAMA
Whole Blood Transcriptional Profiles as a Prognostic Tool in Complete and Incomplete Kawasaki Disease
Adriana H Tremoulet, Jane C Burns, Karen Texter, Octavio Ramilo, PLoS One
Join now to see all

Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2June 2020

Diagnostic Tool Identifies Puzzling Inflammatory Diseases in KidsSeptember 9th, 2024
NIH Provides Research Grant for COVID-19 Detection TechnologyJanuary 11th, 2023
Kawasaki Disease Declines During Pandemic, Offering Clues for PreventionJune 22nd, 2022
Join now to see all

Impact Of TNFA Blockade On Immune Function In Acute Kawasaki DiseaseNational Heart, Lung, And Blood Institute2010–2012
Phase III Infliximab For Primary Treatment Of Kawasaki Disease IND 11046 6/27/200Food And Drug Administration2008–2011
Genetic Markers And Gene Expression In Kawasaki DiseaseNational Heart, Lung, And Blood Institute2006–2010
Genetic Influences And T-Cell Activation In Kawasaki DiseaseNational Heart, Lung, And Blood Institute2008–2009
Matrix Metalloproteinases In Kawasaki DiseaseNational Heart, Lung, And Blood Institute2004–2008
8th International Kawasaki Disease SymposiumNational Heart, Lung, And Blood Institute2005
Genetic Influences &Gene Expression In Kawasaki DiseaseNational Heart, Lung, And Blood Institute2002–2004